Bulgaria's Sopharma sales up 3% y/y in Jan-April

Revenue from sales on the domestic market grew by 11% year-on-year in January-April, whereas export sales went down 2%, Sopharma said in a bourse filing.

In April alone, Sopharma posted a 58% annual surge in sales revenue. The company's export sales soared by 60% on the year, while domestic sales jumped 55%.

As of 1530 CEST on Tuesday, shares in Sopharma traded flat at 6.12 levs ($3.40/3.13 euro) on the Bulgarian Stock Exchange.

(1 euro = 1.95583 levs)